All In MedTech

FDA Clearance Tracker · P170013-S003

Low-Profile Visualized Intraluminal Support (LVIS) and LVIS Jr.

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 25, 2021 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 25, 2021

Approved

Time to decision

93 days

Received Nov 24, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P170013-S003
Device name
Low-Profile Visualized Intraluminal Support (LVIS) and LVIS Jr.
Applicant location
Aliso Viejo, CA
Received
Nov 24, 2020
Decided
Feb 25, 2021
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P170013

Device type

Device class
Class III

Every decision under product code QCA

FDA's approval statement

As written in FDA's record.

Approval for a manufacturing site located at MicroVention, Inc., 35 Enterprise, Aliso Viejo, California 92656.

Source documents

Other decisions for MicroVention, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.